Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04661410 · ClinicalTrials.gov registry record · NA
Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT04661410 is a NA study that has completed, run by Drexel University. The registered enrollment target is 59 participants.
The verdict
NCT04661410, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
In the current study, the investigators will revise our existing 10-session group RRT treatment manual to specifically address the challenges in building social support and enhancing both momentary and sustained reward during the COVID-19 pandemic (Preliminary Aim 1). In months 2-18, the investigators will conduct a small pilot RCT that will randomize individuals to receive either 10-sessions of RRT (n=30) or supportive therapy (n=30), both delivered as group-treatments via videoconferencing software. The specific aims of the current study are to confirm the feasibility and acceptability of RRT for EDs (Primary Aim 1), evaluate the ability of RRT to engage critical targets including reward to day-to-day life activities, reward to palatable foods, social isolation, and loneliness (Primary Aim 2), and provide preliminary estimates of efficacy in reducing ED symptoms at both post-treatment and a 3-month follow-up (Primary Aim 3). the investigators will also evaluate the impact of RRT on secondary outcome variables including depression, substance use, and quality of life (Secondary Aim 1).
Interventions
- BEHAVIORAL Supportive Therapy
- BEHAVIORAL Reward Re-Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2021-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04661410
The ClinicalTrials.gov registry entry for NCT04661410 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Supportive Therapy is the first listed.
NCT04661410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04661410 about?
NCT04661410 is a clinical study titled "Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic". In the current study, the investigators will revise our existing 10-session group RRT treatment manual to specifically address the challenges in building social support and enhancing both momentary and sustained reward during the COVID-19 pandemic (Preliminary Aim 1). In months 2-18, the investigato...
What is the current status of trial NCT04661410?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2020-12-01. Estimated completion is 2021-09-15.
What interventions are being tested in trial NCT04661410?
The interventions under investigation include: Supportive Therapy (BEHAVIORAL), Reward Re-Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04661410?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.